Stocks Overview

LAST PRICE
231.7700
TODAY'S CHANGE (%)
Trending Down-0.0500 (-0.0216%)

Bid / Lots
226.0000/ 2
Ask / Lots
237.0000/ 2
Open / Previous Close
231.4100 / 231.8200
Day Range
Low 230.6450
High 236.8100
52 Week Range
Low 189.4400
High 287.5950
Volume
862,657
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 231.82
Time	Volume	BIIB
09:32 ET	21522	232.64
09:34 ET	2378	233.51
09:36 ET	2718	233.03
09:38 ET	7273	233.9
09:39 ET	10662	233.84
09:41 ET	4110	234.53
09:43 ET	2553	234.94
09:45 ET	2632	235.56
09:48 ET	750	235.16
09:50 ET	1300	235.49
09:52 ET	3270	236.09
09:54 ET	1576	236.69
09:56 ET	800	236.375
09:57 ET	653	236.29
09:59 ET	600	236.02
10:01 ET	2301	236.155
10:03 ET	30331	235.455
10:06 ET	900	234.885
10:08 ET	1982	234.325
10:10 ET	3113	234.155
10:12 ET	23650	234.205
10:14 ET	30107	234.02
10:15 ET	905	233.11
10:17 ET	5017	233.38
10:19 ET	545	232.95
10:21 ET	799	232.61
10:24 ET	1243	232.68
10:26 ET	700	232.47
10:28 ET	100	232.51
10:30 ET	1267	232.375
10:32 ET	1220	232.385
10:33 ET	400	232.58
10:35 ET	1994	232.845
10:37 ET	3458	232.67
10:39 ET	2265	232.78
10:42 ET	1502	233.25
10:44 ET	1677	233
10:46 ET	4664	232.925
10:48 ET	3403	232.715
10:50 ET	500	232.695
10:51 ET	700	232.88
10:53 ET	386	232.82
10:55 ET	1453	232.86
10:57 ET	2490	233
11:00 ET	9833	233.175
11:02 ET	2717	232.6819
11:04 ET	1174	232.71
11:06 ET	2169	233.32
11:08 ET	772	233.12
11:09 ET	4602	233.57
11:11 ET	2918	233.75
11:13 ET	2362	233.605
11:15 ET	367	233.71
11:18 ET	600	233.77
11:20 ET	400	233.77
11:22 ET	1541	233.47
11:24 ET	2739	233.54
11:26 ET	2300	233.45
11:27 ET	3367	232.8
11:29 ET	4242	232.68
11:31 ET	3051	232.43
11:33 ET	800	232.1
11:36 ET	2779	231.61
11:38 ET	300	231.625
11:40 ET	1701	231.765
11:42 ET	1007	231.53
11:44 ET	1385	231.455
11:45 ET	1000	231.3
11:47 ET	1500	231.64
11:49 ET	1381	231.94
11:51 ET	2105	232.24
11:54 ET	951	232.17
11:56 ET	1066	232.05
11:58 ET	300	232.13
12:00 ET	3798	232.41
12:02 ET	3835	232.26
12:03 ET	3473	232.215
12:05 ET	400	232.22
12:07 ET	339	232.35
12:09 ET	753	232.22
12:12 ET	6368	232.52
12:14 ET	1961	232.41
12:16 ET	2116	232.34
12:18 ET	1300	232.25
12:20 ET	300	232.28
12:21 ET	369	232.45
12:23 ET	963	231.58
12:25 ET	200	231.08
12:27 ET	758	231.3298
12:30 ET	854	231.095
12:32 ET	1357	230.87
12:34 ET	1500	231.37
12:36 ET	1100	231.47
12:38 ET	900	231.6
12:39 ET	500	231.455
12:41 ET	821	231.425
12:43 ET	1000	231.43
12:45 ET	3203	231.43
12:48 ET	200	231.41
12:50 ET	300	231.4
12:52 ET	100	231.4
12:54 ET	700	231.39
12:56 ET	2627	231.345
12:57 ET	200	231.165
12:59 ET	600	231.41
01:01 ET	200	231.275
01:03 ET	2075	230.925
01:06 ET	900	231.365
01:08 ET	844	231.42
01:10 ET	100	231.385
01:12 ET	724	231.63
01:14 ET	100	231.435
01:15 ET	281	231.495
01:17 ET	1026	231.385
01:19 ET	677	231.395
01:21 ET	457	231.47
01:24 ET	900	231.6301
01:26 ET	730	231.3801
01:28 ET	100	231.63
01:30 ET	2011	231.81
01:33 ET	200	231.61
01:35 ET	401	231.55
01:37 ET	800	231.47
01:39 ET	100	231.485
01:42 ET	404	231.455
01:44 ET	500	231.26
01:46 ET	489	230.84
01:48 ET	100	230.83
01:50 ET	500	230.92
01:51 ET	200	231
01:53 ET	700	231.08
01:57 ET	100	230.84
02:00 ET	1114	230.69
02:02 ET	900	231.115
02:04 ET	300	231.06
02:06 ET	193	231.06
02:08 ET	835	231.26
02:09 ET	2910	231
02:11 ET	221	231.085
02:13 ET	500	231.18
02:15 ET	300	231.34
02:18 ET	800	231.63
02:20 ET	1269	231.27
02:22 ET	600	231.66
02:24 ET	200	231.525
02:26 ET	700	231.55
02:27 ET	500	231.67
02:29 ET	310	231.76
02:31 ET	269	231.705
02:33 ET	300	231.47
02:36 ET	911	231.745
02:38 ET	400	231.6
02:40 ET	237	231.66
02:42 ET	1200	231.56
02:44 ET	300	231.385
02:45 ET	451	231.71
02:47 ET	500	231.64
02:49 ET	200	231.5
02:51 ET	834	231.57
02:54 ET	1000	231.35
02:56 ET	430	231.5
02:58 ET	112	231.3382
03:00 ET	200	231.33
03:02 ET	500	231.41
03:03 ET	500	231.17
03:05 ET	1359	231.31
03:07 ET	204	231.3
03:09 ET	226	231.3
03:12 ET	200	231.3
03:14 ET	600	231.3
03:16 ET	2609	231.41
03:18 ET	1500	231.76
03:20 ET	1364	231.9665
03:21 ET	1147	231.635
03:25 ET	677	231.88
03:27 ET	1200	231.7
03:30 ET	800	231.72
03:32 ET	327	231.705
03:34 ET	3256	232.09
03:36 ET	1692	232.35
03:38 ET	2241	232.18
03:39 ET	2016	232.26
03:41 ET	957	232.21
03:43 ET	710	232.13
03:45 ET	1200	231.97
03:48 ET	1700	232.21
03:50 ET	900	232.07
03:52 ET	2572	232.185
03:54 ET	2109	231.84
03:56 ET	4692	231.95
03:57 ET	5411	232.085
03:59 ET	12771	231.77

Data delayed at least 15 minutes.

Yesterday

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesBIIB Biogen Inc	33.8B	29.0x	-18.14%
United StatesICLR ICON PLC	25.9B	38.4x	+4.68%
United StatesMRNA Moderna Inc	45.5B	-7.4x	---
United StatesIQV IQVIA Holdings Inc	38.5B	28.4x	+46.62%
United StatesGRFS Grifols SA	5.2B	20.8x	---
United StatesBNTX Biontech SE	19.1B	154.7x	---
As of 2024-07-02

Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. It also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. It commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ.

Contact Information

Headquarters: 225 Binney StreetCAMBRIDGE, MA, United States 02142
Phone: 781-464-2000
Fax: 302-636-5454

Executives

Independent Chairman of the Board: Caroline Dorsa
President, Chief Executive Officer, Director: Christopher Viehbacher
Chief Financial Officer, Executive Vice President: Michael McDonnell
Chief Human Resource Officer, Executive Vice President: Ginger Gregory
Executive Vice President, Chief Legal Officer: Susan Alexander

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$33.8B
Revenue (TTM)	$9.7B
Shares Outstanding	145.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	-0.04
EPS	$8.00
Book Value	$102.14
P/E Ratio	29.0x
Price/Sales (TTM)	3.5
Price/Cash Flow (TTM)	19.9x
Operating Margin	17.21%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Biogen Inc
NASDAQ:BIIBUnited States

Search Criteria

Charts

Recent News

Yesterday

Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join - Contact Levi & Korsinsky, from 3 hours ago by Dow Jones

Investors in Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB, from 3 hours ago by Dow Jones

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, Fastly, and NIKE and Encourages Investors to Contact the Firm, from 4 hours ago by Dow Jones

Contact The Gross Law Firm by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB), from 12 hours ago by Dow Jones

The Schall Law Firm Calls On Biogen Inc Investors Who Have Sustained Losses To Contact Be Mindful Of The Time Limitation In This Situation, from 14 hours ago by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar